Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-Serine Adjuvant Pharmacotherapy for Schizophrenia
NCT00138775Phase 2Unknown
- Sponsor
- Sheba Medical Center
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of d-serine in schizophrenia, schizoaffective disorder, sponsored by Sheba Medical Center. Status: unknown.
02
Drugs
d-serine
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00138775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00138775.